Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 102
- Markets & Stocks
Celadon Signs New £26m Supply Contract, Hemp & Health Turns To Medical Cannabis, While Cellular Goods & Chill Brands Partner Up
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] This morning (November 16), AIM-listed medical cannabis operator Celadon Pharmaceuticals announced that it has signed a new ‘commercial supply agreement’ with an unnamed ‘leading European medical cannabis company’.
- Uncategorized
Michigan Cannabis Sales Dip As Legal Action Against Retailers Gathers Pace
New figures from the Michigan Cannabis Regulatory Agency (MCRA) show that October cannabis sales fell 4.3% compared with September.
- Press releases
PHCANN International Appoints New CEO
PHCANN International has appointed Mr. Sasho Stefanoski as the new Chief Executive Officer (CEO) of the Group.
- Uncategorized
Aurora Hails ‘Strongest Fiscal Year to Date’ As Medical Cannabis Sales to Europe Bolster Balance Sheet
The Canadian cannabis giant Aurora Cannabis published its second quarter results last week, revealing a double-digit jump in revenues and record pre-tax profits.
- Data & Analysis
The Global Cannabis Testing Industry Could Be Worth up to $770m by 2027, New Report States
As the cannabis industry continues to expand and evolve at pace throughout the globe, product testing is becoming an increasingly vital subsector.
- Uncategorized
Florida’s Supreme Court Hears Arguments on Adult Use Legalisation Bill
Florida’s Supreme Court justices heard oral arguments on Wednesday as to whether a bill proposing adult-use cannabis legalisation should be included on the 2024 ballot.
- CBD Market
Phytovista Laboratories Celebrates as a Natural CBD Supplement is Approved for Informed Choice Certification
Phytovista Laboratories, a leading provider of cannabinoid and medicinal product analytical testing services, proudly announces its instrumental role in helping a renowned CBD supplement client become the first product with naturally derived CBD as its primary ingredient to receive approval for Informed Choice certification.
- Uncategorized
Trulieve Q3 Losses Narrow as It Announces Plans to Redeem $130M in Debt
US cannabis MSO Trulieve published its third quarter results this morning, revealing that the company has been able to reduce its losses despite a year-on-year drop in revenues.
- Markets & Stocks
Jazz Pharma Could Be Considering Sale of Cannabis Arm, Ananda Signs New MOU With Nottingham Trent University, & More from Cannovum Cannabis AG
Ananda Developments [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”ANA.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis Stock Exchange-listed UK cannabis company Ananda Developments announced a number of key developments across both of its wholly owned subsidiaries this week.
- Uncategorized
Trees Corp Scraps Merger With 420 Investments
Canadian cannabis company Trees this week announced that its scheduled merger with 420 Investments, announced in July this year, has now been ‘unilaterally terminated’.
- Adult-Use
Switzerland’s Largest Cannabis Pilot Project to Date ‘Perfect Sweet Spot’ to Study Recreational With the Same Research-Based Approach as Medical
Switzerland’s Federal Office of Public Health (FOHP) officially approved the ‘Grashaus Project’ last month, the country’s sixth adult-use cannabis pilot study.
- Uncategorized
Organigram Announces ‘Transformative’ C$124m Investment From Tobacco Giant BAT
Canadian cannabis producer Organigram has announced a further major investment from tobacco giant British American Tobacco (BAT).











